Bruker this week reported a 29 percent jump in first-quarter revenues year over year, posting $357 million in revenues, compared to $277.7 million in the first quarter of 2010.
The company's Bruker Scientific Instruments Segment, which contains its mass spectrometry products, saw revenues climb to $335.8 million, a 29 percent rise from $260.3 million a year ago.
In a statement, Bruker President and CEO Frank Laukien said that new order bookings increased 40 percent year over year, and the firm ended the first quarter with a new backlog record.